Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage

[Needsalife]

Weight loss drugs prices to be slashed some Medicaid/medicare coverage

https://www.cnbc.com/2025/11/06/trump-eli-lilly-novo-nordisk-deal-obesity-drug-prices.html

 

[byefatlicia]

This is good news. And will help drive grey prices even lower🙂

"The event was delayed when a man who was standing behind Trump fainted."
He was reportedly a pharma rep

 

[IshimaruKenta]

"Tirzepatide, the active ingredient in Eli Lilly’s Zepbound and diabetes injection Mounjaro, likely won’t be eligible for those negotiations until the end of the decade."

 

[Biglemon]

Says Zepbound and Mounjaro eligible for $50-149 per month on Medicare and Medicaid. That’s a game changer.

 

[MsGizmo]

Too little too late for me ... but I'm happy for anyone who it does end up helping. Most insurance companies follow the state guidelines and Ohio pretty much bans coverage for weight loss drugs. Not a single plan on the marketplace covers them. I know, I checked.

 

[maxumismarx]

So from $399 down to $349 for the starting doses compared to direct to patient and $449 down from $499 for all other doses for most people not covered on Medicare / Medicaid. $50 off is better than nothing, I guess… 🥴

 

[Good-Heart6425]

https://www.fidelity.com/news/article/investment-news/202511061712BENZINGAFULLNGTH48706737
Under the new deal, Medicare and Medicaid will begin covering obesity medications, including GLP-1 drugs – short for glucagon-like peptide-1 receptor agonists– starting in April 2026.

Patients will see monthly out-of-pocket costs ranging from $50 to $350, depending on dosage and insurance coverage — a sharp reduction from the $1,000-plus price tags many currently face.

Eli Lilly CEO Says ‘Turning Point’ In Obesity Fight​

"This action today will really begin to change the arc of chronic disease in our country," Dave Ricks, CEO of Eli Lilly ( LLY ), said, adding that the reduced cost "opens up access for millions of Medicare beneficiaries."

He cited powerful results from Lilly's Zepbound (tirzepatide), noting its ability to reduce the progression from prediabetes to type 2 diabetes by 94% over three years and showing significant cardiovascular benefits in clinical trials.

Ricks also teased the arrival of Lilly's next-generation pill, orforglipron, a once-daily oral treatment that aims to improve patient convenience

 

[Good-Heart6425]

This is good news. And will help drive grey prices even lower🙂

"The event was delayed when a man who was standing behind Trump fainted."
He was reportedly a pharma rep

Poor guy! Maybe he forgot to eat because his appetite was suppressed?

 

[randompersonrandom]

It's wild how my perspective has changed. I look at this, shrug, and say "Who cares that you're dropping prices to three hundred bucks a month? I can get good, well-tested grey for two-fiddy bucks a YEAR. Don't pee on my leg and tell me the rain is nice this time of year."

 

[byefatlicia]

Don't pee on my leg and tell me the rain is nice this time of year."

They need to stop peeing on the legs of random people 😂

 

[IshimaruKenta]

They need to stop peeing on the legs of random people 😂

Don't tempt me with a good time.